Funding for this research was provided by:
National Natural Science Foundation of China (81801515, 81801494)
Suzhou introduce expert team of clinical medicine (SZYJTD201708, SZYJTD201707)
Suzhou talent training program (GSWS2019005)
Received: 10 December 2019
Revised: 12 March 2020
Accepted: 30 March 2020
First Online: 22 April 2020
Ethics approval and consent to participate
: The use of human ovarian granular cells was in accordance with the relevant guidelines and regulations, and the experimental protocols were approved by the Medical Ethics Committee of the Suzhou Hospital Affiliated to Nanjing Medical University (NJMU-2015-014). All the healthy donors provided written informed consent prior to participation in this study. Our investigation using experimental animals was conducted on the basis of the Nanjing Medical University Animal Center’s specific guidelines and standards.
: Not applicable
: The authors declare no conflicts of interest.